Zydus to exclusively sell two Gadolinium based MRI injectable in US market
Zydus announces exclusive licensing and supply agreement for two Gadolinium
based Magnetic Resonance Imaging (MRI) injectable, contrast agents in the US
Tag: Zydus Lifesciences